rethinkPeptides Search
Menu
Home / Research library
Research citation

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.

RPEP-033652017Lilleby, Wolfgang; Gaudernack, Gustav; Brunsvig, Paal F; Vlatkovic, Ljiljana; Schulz, Melanie; Mills, Kate; Hole, Knut Håkon; Inderberg, Else Marit
evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.

Cancer immunology, immunotherapy : CII, 66(7), 891-901

View on PubMed ↗Publisher’s paper ↗

Citation

Lilleby, Wolfgang; Gaudernack, Gustav; Brunsvig, Paal F; Vlatkovic, Ljiljana; Schulz, Melanie; Mills, Kate; Hole, Knut Håkon; Inderberg, Else Marit. (2017). Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.. Cancer immunology, immunotherapy : CII, 66(7), 891-901. https://doi.org/10.1007/s00262-017-1994-y